Doctor says arthritis research overlooked despite high prevalence
A leading rheumatologist has called for more focus on arthritis research, highlighting a report showing it affects one in seven Australians yet receives only 1%…
A leading rheumatologist has called for more focus on arthritis research, highlighting a report showing it affects one in seven Australians yet receives only 1%…
For patients with end-stage ankle osteoarthritis, total ankle replacement and ankle fusion have similar clinical scores and harms, according to UK findings. Researchers from the…
When real patients have unprecedented positive outcomes to a new treatment, it’s tempting to talk about it as a breakthrough for medical science. This describes…
Patients need to be alert for signs and symptoms of cardiovascular events, say cardiologists.
Study finds on average they display half the cross-neutralising response to Omicron as healthy controls.
The paper is a 'first', and offers useful data to aid clinical decision-making, researchers say.
Infliximab and abatacept nearly halved the risk of death compared with placebo, the US government-backed study shows.
Other immune-modifying therapies don't confer a similar risk, according to findings from a huge database analysis.
UK researchers say their findings represent a 'paradigm shift' in precision medicine for affected patients.
Results could be of direct clinical relevance to rheumatologists, a specialist says.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.